Translational Genomics Research Institute-Led Study Identifies Unique Cells That May Drive Lung Fibrosis
July 09, 2020
July 09, 2020
PHOENIX, Arizona, July 9 -- The Translational Genomics Research Institute issued the following news release:
A groundbreaking study published today and led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, identifies unique lung cells that may drive Idiopathic Pulmonary Fibrosis (IPF), a deadly lung disease that affects hundreds of thousands of Americans, and for which there is no cure.
This is one of the first comprehensive looks at . . .
A groundbreaking study published today and led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, identifies unique lung cells that may drive Idiopathic Pulmonary Fibrosis (IPF), a deadly lung disease that affects hundreds of thousands of Americans, and for which there is no cure.
This is one of the first comprehensive looks at . . .